Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 131Squamous Cell Carcinoma of Head and Neck 75Lung Neoplasms 47Head and Neck Neoplasms 45Urinary Bladder Neoplasms 43Parkinson Disease 4, Autosomal Dominant Lewy Body 33Oropharyngeal Neoplasms 32Nasopharyngeal Carcinoma 31Biliary Tract Neoplasms 31Uterine Cervical Neoplasms 29Cholangiocarcinoma 28Esophageal Squamous Cell Carcinoma 24Neoplasms 23Carcinoma 23Neoplasm Metastasis 22Small Cell Lung Carcinoma 21Ovarian Neoplasms 21Carcinoma, Squamous Cell 20Stomach Neoplasms 18Colorectal Neoplasms 18Carcinoma, Transitional Cell 17Pancreatic Neoplasms 16Esophageal Neoplasms 16Mesothelioma, Malignant 15Gallbladder Neoplasms 15Mouth Neoplasms 14Laryngeal Neoplasms 13Hypopharyngeal Neoplasms 12Endometrial Neoplasms 11Triple Negative Breast Neoplasms 10

Interventions

Cisplatin 3Specimen Handling 2Radiotherapy 2Platinum 2Magnetic Resonance Spectroscopy 2Docetaxel 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2toripalimab 1dehydroftorafur 1X-Rays 1Radiotherapy, Intensity-Modulated 1Radiation 1Observation 1Nivolumab 1Ipilimumab 1Fluorouracil 1Chemoradiotherapy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Paranasal Sinus Neoplasms × Cisplatin × 1 year × Clear all
NCT05075980 2026-04-13

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Mayo Clinic

Phase 2 Active not recruiting
174 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphatic Metastasis, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡